1. Home
  2. NBIX vs LULU Comparison

NBIX vs LULU Comparison

Compare NBIX & LULU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

N/A

Current Price

$152.72

Market Cap

13.2B

Sector

Health Care

ML Signal

N/A

Logo lululemon athletica inc.

LULU

lululemon athletica inc.

N/A

Current Price

$119.55

Market Cap

15.7B

ML Signal

N/A

Company Overview

Basic Information
Metric
NBIX
LULU
Founded
1992
1998
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Apparel
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
13.2B
15.7B
IPO Year
1996
2007

Fundamental Metrics

Financial Performance
Metric
NBIX
LULU
Price
$152.72
$119.55
Analyst Decision
Strong Buy
Hold
Analyst Count
22
25
Target Price
$180.91
$190.26
AVG Volume (30 Days)
1.4M
2.4M
Earning Date
05-05-2026
06-04-2026
Dividend Yield
N/A
N/A
EPS Growth
41.95
N/A
EPS
3.30
1.69
Revenue
$161,626,000.00
$11,102,600,000.00
Revenue This Year
$24.73
$5.52
Revenue Next Year
$13.14
$4.68
P/E Ratio
$45.72
$70.75
Revenue Growth
977.51
4.86
52 Week Low
$122.14
$104.44
52 Week High
$186.12
$225.98

Technical Indicators

Market Signals
Indicator
NBIX
LULU
Relative Strength Index (RSI) 34.68 48.28
Support Level $125.85 $116.63
Resistance Level $160.08 $122.00
Average True Range (ATR) 6.42 3.56
MACD -2.47 -0.13
Stochastic Oscillator 9.54 33.60

Price Performance

Historical Comparison
NBIX
LULU

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

About LULU lululemon athletica inc.

Lululemon Athletica designs, distributes, and markets athletic apparel, footwear, and accessories for women, men, and girls. The company offers pants, shorts, tops, and jackets for both leisure and athletic activities such as yoga and running. Lululemon also sells fitness accessories, such as bags, yoga mats, and equipment. It sells its products through digital channels, a small number of wholesale partners, more than 800 company-owned stores in about two dozen countries in North America, Asia, and Western Europe, and about 45 franchised locations in the Middle East and Europe. The company was founded in 1998 and is based in Vancouver, Canada.

Share on Social Networks: